| Richard Williamson Jr, MD | |
|
320 E North Ave Ste 208, Pittsburgh, PA 15212-4756 | |
| (412) 359-6200 | |
| (412) 359-6617 |
| Full Name | Richard Williamson Jr |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | 320 E North Ave Ste 208, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609040609 | NPI | - | NPPES |
| 103120121 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD457377 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allegheny General Hospital | Pittsburgh, PA | Hospital |
| Grove City Medical Center | Grove city, PA | Hospital |
| Jefferson Hospital | Jefferson hills, PA | Hospital |
| Washington Hospital, The | Washington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
| Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
News Archive
The Lancet has launched a Global Health Portal, which "offers free and unlimited access to all global health content in one location including Series, Regional Reports, multimedia content, and from our World Report and Perspectives sections," according to the journal's homepage.
Six hospitals in Indiana and Alabama have agreed to pay the United States more than $8 million to settle allegations that the health care facilities submitted false claims to Medicare, the Department of Justice announced today.
Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as potentially one of the most potent drugs available to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia.
Optogenetics is a new field of research that introduces light-sensitive proteins into cells in a genetically targeted manner, for example, to obtain information on signalling pathways and the function of neurons in a living organism.
› Verified 6 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
The Lancet has launched a Global Health Portal, which "offers free and unlimited access to all global health content in one location including Series, Regional Reports, multimedia content, and from our World Report and Perspectives sections," according to the journal's homepage.
Six hospitals in Indiana and Alabama have agreed to pay the United States more than $8 million to settle allegations that the health care facilities submitted false claims to Medicare, the Department of Justice announced today.
Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as potentially one of the most potent drugs available to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia.
Optogenetics is a new field of research that introduces light-sensitive proteins into cells in a genetically targeted manner, for example, to obtain information on signalling pathways and the function of neurons in a living organism.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Williamson Jr, MD 320 E North Ave Ste 208, Pittsburgh, PA 15212-4756 Ph: (412) 359-6200 | Richard Williamson Jr, MD 320 E North Ave Ste 208, Pittsburgh, PA 15212-4756 Ph: (412) 359-6200 |
News Archive
The Lancet has launched a Global Health Portal, which "offers free and unlimited access to all global health content in one location including Series, Regional Reports, multimedia content, and from our World Report and Perspectives sections," according to the journal's homepage.
Six hospitals in Indiana and Alabama have agreed to pay the United States more than $8 million to settle allegations that the health care facilities submitted false claims to Medicare, the Department of Justice announced today.
Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as potentially one of the most potent drugs available to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia.
Optogenetics is a new field of research that introduces light-sensitive proteins into cells in a genetically targeted manner, for example, to obtain information on signalling pathways and the function of neurons in a living organism.
› Verified 6 days ago
Pascal Olivier Zinn, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5150 Centre Ave Ste 433, Pittsburgh, PA 15232 Phone: 412-647-7614 Fax: 412-623-4653 | |
Enyinna L Nwachuku, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St, Suite B-400, Pittsburgh, PA 15213 Phone: 412-647-6777 Fax: 412-647-6483 | |
David Zorub, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5200 Centre Ave, Suite 617, Pittsburgh, PA 15232 Phone: 412-623-2972 | |
David Kaufmann, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St, Suite 300, Pittsburgh, PA 15219 Phone: 412-471-4772 | |
Sean Polster, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 Lothrop St Ste 521, Suite B400, Pittsburgh, PA 15213 Phone: 412-647-8186 | |
Dr. Ali Fadhil, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 Locust St Ste 311, Pittsburgh, PA 15219 Phone: 412-647-2304 | |
Daryl Pinion Fields Ii, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 Lothrop St Ste B-400, Pittsburgh, PA 15213 Phone: 320-224-2705 |